Cargando…

Gastrointestinal (GI)-Tract Microbiome Derived Neurotoxins and their Potential Contribution to Inflammatory Neurodegeneration in Alzheimer’s Disease (AD)

The human gastrointestinal (GI)-tract microbiome is a rich, complex and dynamic source of microorganisms that possess a staggering diversity and complexity. Importantly there is a significant variability in microbial complexity even amongst healthy individuals-this has made it difficult to link spec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lukiw, Walter J., Arceneaux, Lisa, Li, Wenhong, Bond, Taylor, Zhao, Yuhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395586/ https://www.ncbi.nlm.nih.gov/pubmed/34457996

Ejemplares similares

Gastrointestinal Tract Microbiome-Derived Pro-inflammatory Neurotoxins in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2021)

Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (Aβ42) Peptide
por: Lukiw, Walter J., et al.
Publicado: (2019)

Gastrointestinal (GI) Tract Microbiome-Derived Neurotoxins—Potent Neuro-Inflammatory Signals From the GI Tract via the Systemic Circulation Into the Brain
por: Lukiw, Walter J.
Publicado: (2020)

Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus
por: Zhao, Yuhai, et al.
Publicado: (2017)

Human gastrointestinal (GI) tract microbiome-derived pro-inflammatory neurotoxins from Bacteroides fragilis: Effects of low fiber diets and environmental and lifestyle factors
por: Lukiw, Walter J
Publicado: (2020)

Down-Regulation of Essential Synaptic Components by GI-Tract Microbiome-Derived Lipopolysaccharide (LPS) in LPS-Treated Human Neuronal-Glial (HNG) Cells in Primary Culture: Relevance to Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2019)

The microbiome, microbial-generated proinflammatory neurotoxins, and Alzheimer's disease
por: Lukiw, Walter J.
Publicado: (2016)

Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD)
por: Hill, James M., et al.
Publicado: (2014)

The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease
por: Hill, James M., et al.
Publicado: (2014)

Aluminum and its potential contribution to Alzheimer's disease (AD)
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2014)

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2022)

Natural and Synthetic Neurotoxins in Our Environment: From Alzheimer’s Disease (AD) to Autism Spectrum Disorder (ASD)
por: Pogue, Aileen I, et al.
Publicado: (2016)

Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2018)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
por: Lukiw, Walter J., et al.
Publicado: (2020)

Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2022)

Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer’s Disease Brain
por: Zhao, Yuhai, et al.
Publicado: (2017)

Neurofilament Light (NF-L) Chain Protein from a Highly Polymerized Structural Component of the Neuronal Cytoskeleton to a Neurodegenerative Disease Biomarker in the Periphery
por: Zhao, Yuhai, et al.
Publicado: (2021)

Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an update
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2014)

MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer’s Disease (AD)-Novel and Unique Pathological Features
por: Zhao, Yuhai, et al.
Publicado: (2015)

Lipopolysaccharide (LPS) Accumulates in Neocortical Neurons of Alzheimer’s Disease (AD) Brain and Impairs Transcription in Human Neuronal-Glial Primary Co-cultures
por: Zhao, Yuhai, et al.
Publicado: (2017)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020)

Treating Alzheimer’s Disease (AD) with Light and Sound
por: Lukiw, Walter J
Publicado: (2020)

Alzheimer's disease and the microbiome
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2013)

SARS-CoV-2, long COVID, prion disease and neurodegeneration
por: Zhao, Yuhai, et al.
Publicado: (2022)

Over-Expressed Pathogenic miRNAs in Alzheimer’s Disease (AD) and Prion Disease (PrD) Drive Deficits in TREM2-Mediated Aβ42 Peptide Clearance
por: Zhao, Yuhai, et al.
Publicado: (2016)

Alzheimer's disease (AD) as a disorder of the plasma membrane
por: Lukiw, Walter J.
Publicado: (2013)

Circular RNA (circRNA) in Alzheimer's disease (AD)
por: Lukiw, Walter J.
Publicado: (2013)

Genetics of Aggression in Alzheimer’s Disease (AD)
por: Lukiw, Walter J., et al.
Publicado: (2017)

MicroRNA (miRNA) Complexity in Alzheimer’s Disease (AD)
por: Lukiw, Walter J.
Publicado: (2023)

Microbial-generated amyloids and Alzheimer's disease (AD)
por: Hill, James M., et al.
Publicado: (2015)

Effects of Dietary Yogurt on the Healthy Human Gastrointestinal (GI) Microbiome
por: Lisko, Daniel J., et al.
Publicado: (2017)

Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer’s Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7)
por: Zhao, Yuhai, et al.
Publicado: (2016)

microRNA-146a Signaling in Alzheimer's Disease (AD) and Prion Disease (PrD)
por: Lukiw, Walter J.
Publicado: (2020)

Melanoma and the Gastrointestinal (GI) Tract: Maintaining a High Index of Suspicion
por: Syed, Hassnain R, et al.
Publicado: (2021)

microRNA-34a (miRNA-34a) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2019)

Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2016)

Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer’s Disease (AD) and Prion Disease (PrD)
por: Lukiw, Walter J.
Publicado: (2022)

Young patients and gastrointestinal (GI) tract malignancies - are we addressing the unmet needs?
por: Perl, G., et al.
Publicado: (2016)

Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD)
por: Lukiw, Walter J.
Publicado: (2013)

NF-kB (p50/p65)-Mediated Pro-Inflammatory microRNA (miRNA) Signaling in Alzheimer's Disease (AD)
por: Lukiw, Walter J.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gfsa3470fdng0e2im8dmpu957f